Cargando…
Therapeutic Plasma Exchange in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis of Comparative Evidence
Background: Patients with Myasthenia Gravis (MG) can be treated acutely with therapeutic plasma exchange (TPE) or intravenous immune globulin (IVIG). To date, there is no definitive understanding of which of the two treatments is more effective and safer. The purpose of this study was to systematica...
Autores principales: | Ipe, Tina S., Davis, Adeola R., Raval, Jay S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439193/ https://www.ncbi.nlm.nih.gov/pubmed/34531809 http://dx.doi.org/10.3389/fneur.2021.662856 |
Ejemplares similares
-
Therapeutic plasma exchange in the treatment of myasthenia gravis
por: Kumar, Rajesh, et al.
Publicado: (2015) -
Lymphoplasmapheresis versus plasma exchange in severe myasthenia gravis: a retrospective cohort study
por: Duan, Weiwei, et al.
Publicado: (2023) -
Outcome of therapeutic plasma exchange in Myasthenia gravis patients
por: Dogra, Ashu, et al.
Publicado: (2020) -
Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021) -
Novel Treatments in Myasthenia Gravis
por: Menon, Deepak, et al.
Publicado: (2020)